Evidence map›Paper›PMID 26110759›Full record

ArticlePloS one2015

Structural and Functional Analysis of Human HtrA3 Protease and Its Subdomains.

Przemyslaw Glaza, Jerzy Osipiuk, Tomasz Wenta, Dorota Zurawa-Janicka, Miroslaw Jarzab, Adam Lesner, Bogdan Banecki, Joanna Skorko-Glonek, Andrzej Joachimiak, Barbara Lipinska

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Properties of the HtrA Protease From BacteriumFrontiers in microbiology · 2019
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Przemyslaw GlazaDepartment of Biochemistry, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
Jerzy OsipiukMidwest Center for Structural Genomics, Argonne National Laboratory, Argonne, Illinois, IL 60439, United States of America; Structural Biology Center, Biosciences Division, Argonne National Laboratory, Argonne, Illinois, IL 60439, United States of America.
Tomasz WentaDepartment of Biochemistry, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
Dorota Zurawa-JanickaDepartment of Biochemistry, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
Miroslaw JarzabDepartment of Biochemistry, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
Adam LesnerDepartment of Biochemistry, Faculty of Chemistry, University of Gdansk, 80-308 Gdansk, Poland.
Bogdan BaneckiDepartment of Molecular and Cellular Biology, Intercollegiate Faculty of Biotechnology of the University of Gdansk and the Medical University of Gdansk, 80-822 Gdansk, Poland.
Joanna Skorko-GlonekDepartment of Biochemistry, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
Andrzej JoachimiakMidwest Center for Structural Genomics, Argonne National Laboratory, Argonne, Illinois, IL 60439, United States of America; Structural Biology Center, Biosciences Division, Argonne National Laboratory, Argonne, Illinois, IL 60439, United States of America.
Barbara LipinskaDepartment of Biochemistry, Faculty of Biology, University of Gdansk, 80-308 Gdansk, Poland.
University of Gdańsk · PLArgonne National Laboratory · USGdańsk Medical University · PL

Funding

Midwest Center for Structural GenomicsU54GM094585 · NIGMS · UNIVERSITY OF CHICAGO · PI MINOR, WLADEK · 2010 to 2014
$33.7M
NIGMS NIH HHS GM094585NIGMS NIH HHS U54 GM094585
6 · The paper itself

Abstract

Human HtrA3 protease, which induces mitochondria-mediated apoptosis, can be a tumor suppressor and a potential therapeutic target in the treatment of cancer. However, there is little information about its structure and biochemical properties. HtrA3 is composed of an N-terminal domain not required for proteolytic activity, a central serine protease domain and a C-terminal PDZ domain. HtrA3S, its short natural isoform, lacks the PDZ domain which is substituted by a stretch of 7 C-terminal amino acid residues, unique for this isoform. This paper presents the crystal structure of the HtrA3 protease domain together with the PDZ domain (ΔN-HtrA3), showing that the protein forms a trimer whose protease domains are similar to those of human HtrA1 and HtrA2. The ΔN-HtrA3 PDZ domains are placed in a position intermediate between that in the flat saucer-like HtrA1 SAXS structure and the compact pyramidal HtrA2 X-ray structure. The PDZ domain interacts closely with the LB loop of the protease domain in a way not found in other human HtrAs. ΔN-HtrA3 with the PDZ removed (ΔN-HtrA3-ΔPDZ) and an N-terminally truncated HtrA3S (ΔN-HtrA3S) were fully active at a wide range of temperatures and their substrate affinity was not impaired. This indicates that the PDZ domain is dispensable for HtrA3 activity. As determined by size exclusion chromatography, ΔN-HtrA3 formed stable trimers while both ΔN-HtrA3-ΔPDZ and ΔN-HtrA3S were monomeric. This suggests that the presence of the PDZ domain, unlike in HtrA1 and HtrA2, influences HtrA3 trimer formation. The unique C-terminal sequence of ΔN-HtrA3S appeared to have little effect on activity and oligomerization. Additionally, we examined the cleavage specificity of ΔN-HtrA3. Results reported in this paper provide new insights into the structure and function of ΔN-HtrA3, which seems to have a unique combination of features among human HtrA proteases.

Indexed as

Amino Acid SequenceCrystallography, X-RayHumansModels, MolecularMolecular Sequence DataPDZ DomainsProtein IsoformsProtein MultimerizationProtein Structure, SecondaryProtein SubunitsSerine EndopeptidasesStructure-Activity RelationshipHTRA3 protein, humanProtein IsoformsProtein SubunitsSerine Endopeptidases

Identifiers

PMID26110759
PMCPMC4481513
OpenAlexW1492713468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.